VERAX BIOMEDICAL INC

Profile

Company Names

VERAX BIOMEDICAL INC

Addresses

C/O VERAX BIOMEDICAL INCORPORATED, 148 BARTLETT STREET, MARLBOROUGH, MA 01752

148 BARTLETT STREET, MARLBOROUGH, MA 01752

377 PLANTATION STREET, WORCESTER, MA 01605

4 BIOTECH, 377 PLANTATION STREET, WORCESTER, MA 01605

4 BIOTECH, 377 PLANTATION STREET, WORCESTER, MA 01605

Phone Numbers

(508) 755-7029
508-755-7029
508-755-7049

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DE

Total Amount Raised:

$45,756,577.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2019-09-05 
$2,538,912.00 
$10,538,912.00 
$8,000,000.00 
Debt 
7
2017-10-26 
$11,439,595.00 
$24,090,000.00 
$12,650,405.00 
Equity 
6
2016-02-18 
$12,614,469.00 
$24,548,586.00 
$11,934,117.00 
Equity, Debt 
5
2015-01-07 
$4,000,000.00 
$4,000,000.00 
$0.00 
Equity 
4
2013-07-22 
$8,499,302.00 
$11,781,992.00 
$3,282,690.00 
Equity, Debt 
3
2012-07-31 
$3,298,121.00 
$5,000,000.00 
$1,701,879.00 
Debt 
2
2011-03-09 
$1,287,036.00 
$1,287,036.00 
$0.00 
Equity 
1
2009-04-02 
$2,079,142.00 
$10,000,000.00 
$7,920,858.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ROBERT 
 
FLANAGAN 
DIRECTOR
MARC 
E. 
GOLDBERG 
DIRECTOR
JEFFREY 
A. 
HALL 
EXECUTIVE OFFICER
NANCY 
A. 
HORNBAKER 
EXECUTIVE OFFICER
JAMES 
 
KOZIARZ 
DIRECTOR
GREG 
 
LAWRENCE 
EXECUTIVE OFFICER
GREGORY 
 
LAWRENCE 
EXECUTIVE OFFICER
R. 
SCOTT 
MCKENZIE 
EXECUTIVE OFFICER
R. 
SCOTT 
MCKENZIE, SR. 
EXECUTIVE OFFICER
PAUL 
 
RAGUSA 
EXECUTIVE OFFICER
JOE 
 
SANDERS 
EXECUTIVE OFFICER, DIRECTOR
JOE 
R. 
SANDERS 
EXECUTIVE OFFICER, DIRECTOR
YLI 
REMO 
VALLEJO 
EXECUTIVE OFFICER
ROBERT 
 
ZIESERL 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2019-09-05 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-10-26 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2016-02-18 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2016-02-18 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-01-07 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2013-07-22 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2013-07-22 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-07-31 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-07-31 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-03-09 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-04-02 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
THOMAS FREDERICK ZIPSER
FOUR POINTS CAPITAL PARTNERS LLC